HACE1 mediates the non-proteolytic ubiquitination of cyclin C in the cytoplasm, thereby promoting nuclear–mitochondrial translocation of cyclin C and maintaining the chemosensitivity of gastric cancer cells to cisplatin (118). The gene discussed is HACE1; the disease is gastric cancer.